RECENT NEWS

Cambridge’s Papworth Hospital pilots Steriwave

The Royal Papworth Hospital NHS Foundation Trust, one of the world’s foremost cardiothoracic centres, is launching a pilot programme with Ondine’s Steriwave nasal photodisinfection therapy.

Cancer deaths expected to rise to over 18 million in 2050

There has been a rapid increase in the global number of cancer cases and deaths between 1990 and 2023, despite advances in cancer treatment and efforts to tackle cancer risk factors over that same time period.

BMA reports that most GP surgeries are 'unfit for the future'

Hundreds of GP surgeries are not fit for purpose, and many are not equipped or suitable to meet the ever-growing patient demand. Those are the findings of a BMA survey of nearly 2,000 GPs and practice managers. They reveal widespread concern about the state of surgeries across England; mould growing in waiting rooms, treatment rooms with cracked walls and inadequate space for staff to work in.

Medical tribunals get greater clarity in decision making for cases of sexual misconduct

New guidance from the Medical Practitioners Tribunal Service (MPTS) will support tribunals making decisions about doctors facing serious allegations, including sexual misconduct, discrimination and violent and abusive behaviours.

AI breakthroughs predict painful crises in sickle cell disease before they strike

​Millions of patients worldwide living with sickle cell disease (SCD) could soon have the power to anticipate painful vaso-occlusive crises (VOCs) before they occur, thanks to an artificial intelligence platform developed by Sanius Health, a London-based digital health company.

New research trial testing stem cell transplants for severe scleroderma

Sheffield Teaching Hospitals NHS Foundation Trust has become the only site in the UK to open a groundbreaking international trial which could revolutionise care for people living with a rare and degenerative disease that causes hardening and tightening of the skin and connective tissues.

Serchem acquires Serve Medical

A Telford-based global chemical manufacturer has strengthened its healthcare decontamination expertise by acquiring a respected provider of validation and servicing for hospital decontamination units. Serchem, based on Hortonwood 10, has acquired Serve Medical, based at The Ercall Suite on Stafford Park, bringing together two trusted Telford businesses.

Radar Healthcare welcomes Dr Dominique Allwood to its board of directors as non-executive director

Radar Healthcare has announced the appointment of Dr Dominique Allwood to its Board of Directors, marking a significant milestone in the company’s journey to transform healthcare through data-driven innovation and intelligent systems.

NHS waiting lists drive patients to risky choices

A new study has revealed how NHS waiting lists are pushing patients into risky choices - with some delaying or even avoiding care altogether, despite potential cancer symptoms.

Survival has doubled for people with multiple myeloma

People diagnosed with multiple myeloma – one of the most common forms of blood cancer – are now living nearly twice as long on average as they were in 2005, according to a new study.

NCHA launches first clinical homecare career and competence framework

The National Clinical Homecare Association (NCHA) and Skills for Health have launched the UK’s first career and competence framework for clinical and nursing roles in clinical homecare services. Currently, over 650,000 people in the UK benefit from clinical homecare, which enables patients to live more independently while receiving high-quality care in their own homes.

New NHS online hospital to give patients more control over their care

The NHS is setting up an ‘online hospital’ – NHS Online – in a significant reform to the way healthcare is delivered in England. The new model of care will not have a physical site, instead digitally connecting patients to expert clinicians anywhere in England. The first patients will be able to use the service from 2027.

BD Partners with South West Blood Bikes to support lifesaving medical deliveries across Devon

BD UK&I has announced a new partnership with South West Blood Bikes, a volunteer-led charity providing free, urgent medical courier services across Devon.

Funding offered for innovation in tackling antimicrobial resistance

PACE (Pathways to Antimicrobial Clinical Efficacy) has launched its third funding round, supporting innovative projects that tackle resistant bacterial infections posing the greatest threat to global health.

AI to be trialled at unprecedented scale across NHS screening

Millions of patients could receive quicker diagnoses and treatment, as pioneering AI tools are tested on an unprecedented scale in NHS screening services, thanks to a ground-breaking new cloud system.

Patients treated more quickly as NHS productivity rises over year

New data shows NHS productivity for acute trusts increased by 2.7% over the past year - between April 2024 and March 2025 - exceeding the government’s 2% year-on-year target set in the 10 Year Health Plan.

Gene therapy appears to slow Huntington’s disease progression

UCL scientists have reported that a new Huntington’s disease treatment has shown positive results. The researchers found that patients receiving the treatment experienced 75% less progression of the disease overall, compared to a matched cohort of people with Huntington’s who were not receiving the treatment.

AfPP sets the standard: Circle Health Group achieves Accreditation across 49 hospitals

The Association for Perioperative Practice (AfPP) has marked a major milestone in its mission to improve patient safety, with all 49 hospitals with operating theatres within Circle Health Group now fully accredited under AfPP’s Theatre Accreditation and Audit programme.

Novel nanovaccine halts tumour growth and reduces cancer recurrence

Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and National Centre for Nanoscience and Technology, the Chinese Academy of Sciences (CAS), have jointly developed an approach to significantly reduce the risk of cancer recurrence and metastasis after surgery, by targeting both bulk cancer cells and the elusive cancer stem cells (CSCs) responsible for relapse.

Oral microbes linked to increased risk of pancreatic cancer

Twenty-seven species of bacteria and fungi among the hundreds that live in people’s mouths have been collectively tied to a 3.5 times greater risk of developing pancreatic cancer, a study led by NYU Langone Health and its Perlmutter Cancer Center shows.

Latest Issues

BACCN Conference 2025

Blackpool
7th - 8th October 2025

CSC Autumn Meeting

Ramada Plaza, Wrexham
13th October 2025

VyvaExperts25

Virtual
30th - 31st October 2025